⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Securities Fraud Class Action Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - Levi & Korsinsky Reminds Investors of September 14, 2026
accessnewswire.com
REGN
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
globenewswire.com
REGN
Correction: Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
globenewswire.com
JNJ
BNTX
GMAB
IMUX
INO
PDSB
AZN
GSK
MRK
BIIB
EXEL
REGN
CUE
IOBT
RAPT
PRE
Contact Levi & Korsinsky by September 14, 2026 to Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN
Levi & Korsinsky Urges Regeneron (REGN) Shareholders to Act Before Lead Plaintiff Deadline September 14, 2026
accessnewswire.com
REGN
Recover Investment Losses: Class Action Initiated Against Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
REGN
The Gross Law Firm Reminds Regeneron Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGN
prnewswire.com
REGN
REGN Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Regeneron Pharmaceuticals Securities Lawsuit - Contact SueWallSt
globenewswire.com
REGN
Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Join Class Action Before September 14, 2026 - Contact Levi & Korsinsky
accessnewswire.com
REGN